Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases

Journal of Clinical Oncology

Volumn 20, Issue 17, 2002, Pages 3644-3650

  Antonadou, D ^a   Paraskevaidis, M ^a   Sarris, G ^a   Coliarakis, N ^a   Economou, I ^a   Karageorgis, P ^a   Throuvalas, N ^a  

^a METAXA CANCER HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; CORTICOSTEROID; TEMOZOLOMIDE;

ADULT; ARTICLE; BLOOD TOXICITY; BRAIN METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUROLOGIC EXAMINATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SICKNESS; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; RADIOTHERAPY; SURVIVAL RATE;

EID: 0036731532     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.04.140     Document Type: Article

References (38)

1. Treatment of metastatic cancer
2. Surgical treatment of multiple brain metastases
3. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age
4. A randomized trial of surgery in the treatment of single metastases to the brain
5. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis
6. The role of radiation therapy in the treatment of brain metastases
7. Radiation-induced dementia in patients cured of brain metastases
8. Radiation therapy for intracranial metastatic neoplasia
9. Sites of primary malignancies in patients presenting with cerebral metastases: A review of 120 cases
10. Radiation response of the central nervous system
11. Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis
12. The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the Radiation Therapy Oncology Group
13. Single metastases in the brain: Late results in 325 cases
14. Primary chemotherapy of brain metastasis in small-cell lung cancer
15. Concomitant brain radiotherapy and vinorelbine-ifosfamide-cisplatin chemotherapy in brain metastases of non-small cell lung cancer
16. Response of brain metastases from breast cancer to systemic chemotherapy
17. The Charing Cross Hospital experience with temozolomide in patients with gliomas
18. Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)
19. Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours
20. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse: Temodal Brain Tumor Group
21. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
22. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
23. Pharmacokinetics of 3-methyl-(triazen-1-yl) imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer
24. Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer
25. Plasma and cerebrospinal fluid pharmacokinetics of temozolomide
26. Pharmacokinetic study of temozolomide penetration into CSF in a patient with dural melanoma
27. Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies
28. Phase I trial of temozolomide using an extended continuous oral schedule
29. Survival of human glioma cells treated with various combination of temozolomide and x-rays
30. New approaches for temozolomide therapy: Use in newly diagnosed glioma
31. Treatment of brain metastases of small-cell lung cancer: Comparing teniposide and teniposide with whole-brain radiotherapy - A phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group
32. Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer
33. Neoplasms of the central nervous system
34. Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer
35. Effects of temozolomide (TMZ) on central nervous system (CNS) relapse in patients with advanced melanoma
36. Medical treatment of brain metastases from solid tumours
37. Identification of prognostic factors in patients with brain metastases: A review of 1292 patients
38. Brain metastases in breast cancer: Prognostic factors and management